Monday, June 3, 2024

BREAKING--Moderna Receives U.S. FDA Approval for mRNA RSV Vaccine mRESVIA(R)

By Peter A. McCullough, MD, MPH Many have approached me at large events and have expressed concerns that the vaccine manufacturers where going to use mRNA on a non-emergency basis to make new and routine vaccinations for children and adults.